We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 1.00 (1.77%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 57.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

11 Aug 2016 14:06

RNS Number : 9609G
British Smaller Companies VCT2 Plc
11 August 2016
 

British Smaller Companies VCT2 plc

Unaudited Interim Results and Interim Management Report

For the 6 months ended 30 June 2016

British Smaller Companies VCT2 plc ("the Company") today announces its unaudited interim results for the six months to 30 June 2016.

Financial Highlights

· Increase in total return of 0.6 pence per ordinary share to 111.5 pence per ordinary share (110.9 pence per ordinary share as at 31 December 2015).

· Increase in net asset value per share ("NAV") to 63.5 pence per ordinary share prior to the payment of dividends during the period totalling 2.5 pence per ordinary share. This growth was 1.0 per cent of the opening NAV of 62.9 pence per ordinary share.

· £2.4 million generated from realisation of investments.

· Total cumulative dividends paid since inception of 50.5 pence per ordinary share.

· Completion of the first investment under the new VCT rules.

Chairman's Statement

Your Company's portfolio delivered a total return of 2.1 per cent of its opening value, with income from investments 10.8 per cent higher than the same period last year.

Net asset value increased by 0.6 pence per ordinary share to 63.5 pence per ordinary share, prior to the payment of the final dividend of 2.5 pence per ordinary share for the year ended 31 December 2015 and your Company's total return increased to 111.5 pence per ordinary share.

Investment rate

Following the publication of HMRC's guidance notes in May 2016 the flow of advance approvals from HMRC for new investments increased towards the end of the period. One investment of £0.9 million was completed into Sipsynergy, a market-leading cloud collaboration solutions provider, and a further two potential investments have subsequently received advance assurance.

Financial Results and Dividends

The movement in net asset value per ordinary share and the dividends paid are set out in the table below:

 

Pence per

ordinary share

£000

NAV at 1 January 2016

 

62.9

 

54,850

Net underlying increase in portfolio

0.5

 

448

 

Net income

0.3

 

310

 

Purchase of own shares

-

 

(138)

 

Issue of new shares

(0.2)

 

3,906

 

 

0.6

 

4,526

 

Dividends paid

(2.5)

 

(2,322)

 

 

 

(1.9)

 

2,204

NAV at 30 June 2016

 

61.0

 

57,054

Cumulative dividends paid

 

50.5

 

 

Total Return: at 30 June 2016

 

at 31 December 2015

 

111.5

 

110.9

 

 

 

The portfolio produced a value gain of £0.4 million, representing a 1.2 per cent increase over the opening value and equivalent to an increase in value for shareholders of 0.5 pence per ordinary share.

During the period a final dividend in respect of the year ended 31 December 2015 of 2.5 pence per ordinary share was paid, bringing the cumulative dividends paid to date to 50.5 pence per ordinary share.

The longer-term objective is to produce a consistent and, where possible, increasing dividend stream while maintaining capital value. Your Board has proposed an interim dividend of 2.0 pence per ordinary share for the period to 30 June 2016. When combined with the final dividend in respect of the year ended 31 December 2015, dividends paid in the current financial year total 4.5 pence per ordinary share (2015: 4.5 pence per share). The interim dividend will be paid on 26 September 2016 to shareholders on the register at 26 August 2016.

Shareholder Relations

As part of the Board's continuing dialogue with shareholders, the 21st shareholder workshop was held in conjunction with British Smaller Companies VCT plc at the British Library on 17 May 2016, with over 200 attendees. There were presentations from the managing directors of two of our newest investments, Ness (Holdings) Limited and KeTech Enterprises Limited, David Hall and David Bell from the Investment Adviser, as well as Wyndham North of HM Treasury.

Your Company's electronic communications policy, whereby documents such as the annual report are disseminated via the website www.bscfunds.com rather than by post, has saved on printing costs as well as being more environmentally friendly. I am pleased to report that this policy has been well received, with 83 per cent of shareholders now receiving communications in this way.

The website www.bscfunds.com is refreshed on a regular basis, with the emphasis on providing a comprehensive level of information in a user friendly format.

Outlook

Although the medium to long-term impact of the UK's decision to leave the European Union remains unclear, we are confident that the businesses in which your Company has invested will maintain or adapt their growth strategies as appropriate, with many exporters seeing a potential short-term benefit from the devaluation of sterling against several major currencies.

Whilst the introduction of the new VCT rules has imposed a number of restrictions on the types of companies and transactions in which your Company can invest, we remain positive that the Investment Adviser will continue to be able to source high quality opportunities across its office network which comply with these rules.

Notwithstanding the recent changes in legislation, your Board remains committed to continuing to build and further diversify its portfolio of private company investments, and pursuing an objective of paying a regular dividend.

Objectives and Strategy

The Company's objective is to provide investors with an attractive long-term tax free dividend yield whilst seeking to maintain and build the capital value of their investment and maintain the Company's status as a venture capital trust.

The investment strategy of the Company is to create a portfolio with a mix of companies operating in traditional industries and those that offer opportunities in the development and application of innovation.

The Company invests in UK businesses across a broad range of sectors including but not limited to Software, IT & Telecommunications, Business Services, Manufacturing & Industrial Services, Retail & Brands and Healthcare in VCT qualifying and non-qualifying securities.

Investment Review

The Company's portfolio at 30 June 2016 had a value of £35.8 million consisting of £34.0 million (95 per cent) in unquoted investments and £1.8 million (5 per cent) in quoted investments. The strategy to increase the portfolio diversity is signified insofar as the largest single investment represents just 5.7 per cent of the net asset value.

Over the six months to 30 June 2016 the portfolio saw an underlying value gain of £0.4 million with good progress being made across a number of companies. The most significant movements in valuations during the period were:

• ACC Aviation

£0.5 million

• GTK (Holdco) Limited

£0.3 million

 

These gains were partially offset by companies which saw profits impacted by difficult trading conditions:

• Seven Technologies Holdings Limited

down £0.3 million

• Ness (Holdings) Limited

down £0.3 million

 

New and Follow-on Investments

In the six months to June 2016 the Company has made a new investment of £0.9 million into Sipsynergy (via Hosted Network Services Limited), and a follow-on investment of £0.2 million into Immunobiology Limited.

Realisation of Investments

During the six months to 30 June 2016 the Company received £2.4 million from disposals and repayments of loans. This included the full exit from its investment in Callstream Group Limited and the sale or reduction of a number of AIM holdings following a period of strong share price performance.

A detailed analysis of all investments realised in the period to 30 June 2016 can be found in note 6 to this interim report.

Investment Portfolio

The top ten investments had a combined value of £19.8 million, 55.4 per cent of the total portfolio.

Sector

Name of Company

Date

of initial

investment

Current

cost

£000

Realised

proceeds

to date

£000

Investment

Valuation

at 30 June

2016

£000

Valuation

plus

proceeds

to date

£000

Business Services

Intelligent Office (via IO Outsourcing Limited)

May 14

1,956

-

3,264

3,264

Business Services

ACC Aviation (via Newacc (2014) Limited)

Nov 14

1,379

-

2,274

2,274

Healthcare

Mangar Health Limited

Jan 14

1,640

-

2,273

2,273

Software

KeTech Enterprises Limited

Nov 15

2,000

-

2,000

2,000

Manufacturing

GTK (Holdco) Limited

Oct 13

813

337

1,845

2,182

Business Services

DisplayPlan Holdings Limited

Jan 12

70

820

1,830

2,650

Retail

Gill Marine Holdings Limited

Sep 13

1,870

-

1,717

1,717

Business Services

Springboard Research Holdings Limited

Oct 14

1,646

-

1,646

1,646

Software

Business Collaborator Limited

Nov 14

1,340

-

1,501

1,501

Healthcare

Immunobiology Limited

Jun 03

2,382

-

1,486

1,486

Top Ten Investments

 

15,096

1,157

19,836

20,993

Remaining Unquoted Portfolio

 

 

 

 

 

Manufacturing

Leengate Holdings Limited

Dec 13

934

-

1,372

1,372

Manufacturing

Cambrian Park & Leisure Homes Limited (via Cambrian Lodges Holdings Limited)

Oct 14

1,100

100

1,078

1,178

Manufacturing

The Heritage Window Company Holdco Limited

Sep 14

1,468

-

954

954

Software

Sipsynergy

(via Hosted Network Services Ltd)

Jun 16

900

-

900

900

Software

Seven Technologies Holdings Limited

Apr 12

1,238

762

899

1,661

Software

Intamac Systems Limited

Jun 14

828

-

828

828

Business Services

Macro Art Holdings Limited

Jun 14

679

160

809

969

Manufacturing

Wakefield Acoustics

 (via Malvar Engineering Limited)

Dec 14

730

31

750

781

Retail

Harvey Jones Holdings Limited

May 07

442

751

617

1,368

Software

PowerOasis Limited

Nov 11

594

-

594

594

Retail & Manufacturing

Bagel Nash Group Limited

Jul 11

629

200

539

739

Retail

Ness (Holdings) Limited

Mar 15

1,031

-

516

516

Software

Selima Holding Company Ltd

Mar 12

300

-

509

509

Other investments

£0.5 million and below

 

3,493

349

3,760

4,109

Total unquoted investments

 

29,462

3,510

33,961

37,471

Quoted Portfolio

 

 

 

 

 

Manufacturing

Gooch & Housego plc

Jan 15

397

-

510

510

Other investments

£0.5 million and below

 

1,124

881

1,321

2,202

Total quoted investments

 

1,521

881

1,831

2,712

Total Portfolio

 

30,983

4,391

35,792

40,183

Full disposals to date

 

18,810

25,613

-

25,613

Total Investment portfolio 

 

49,793

30,004

35,792

65,796

 

The charts on page 12 of the interim report show the composition of the portfolio as at 30 June 2016 by industry sector, age of investment, investment instrument and the value compared to cost and shows diversity across a wide range of industry sectors.

Principal Risks and Uncertainties

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 December 2015. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 Income Tax Act 2007.

In summary, the principal risks are:

• Loss of approval as a Venture Capital Trust;

• Economic;

• Investment and strategic;

• Regulatory;

• Reputational;

• Operational;

• Financial; and

• Market/liquidity.

 

Full details of the principal risks can be found in the financial statements for the year ended 31 December 2015 on pages 30 and 31, a copy of which is available at www.bscfunds.com.

Directors' Responsibilities Statement

The directors of British Smaller Companies VCT2 plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the EU, and give a fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT2 plc, and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT2 plc are listed in note 9.

By order of the Board

Richard Last

Chairman

11 August 2016

Unaudited Statement of Comprehensive Income

for the six months ended 30 June 2016

 

 

Unaudited 6 months ended

30 June 2016

Unaudited 6 months ended

30 June 2015

 

Notes

Revenue

Capital

Total

Revenue

Capital

Total

 

 

£000

£000

£000

£000

£000

£000

Gain on investments held at fair value

 

-

262

262

-

1,709

1,709

Gain (loss) on disposal of investments

 

-

186

186

-

(53)

(53)

Income

2

1,083

-

1,083

965

-

965

Total income

 

1,083

448

1,531

965

1,656

2,621

Administrative expenses:

 

 

 

 

 

 

 

Investment Adviser's fee

 

(136)

(412)

(548)

(98)

(295)

(393)

Other expenses

 

(225)

-

(225)

(222)

-

(222)

 

 

(361)

(412)

(773)

(320)

(295)

(615)

Profit before taxation

 

722

36

758

645

1,361

2,006

Taxation

3

(75)

75

-

(76)

76

-

Profit for the period

 

647

111

758

569

1,437

2,006

Total comprehensive income for the period

 

647

111

758

569

1,437

2,006

Basic and diluted earnings per ordinary share

5

0.70p

0.12p

0.82p

0.72p

1.81p

2.53p

 

The Total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRSs'). The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('SORP') 2014 published by the Association of Investment Companies.

Unaudited Balance Sheet

as at 30 June 2016

 

Notes

Unaudited

30 June

2016

 

Unaudited

30 June

2015

 

Audited

31 December

2015

 

 

 

£000

£000

£000

Assets

 

 

 

 

Non-current assets

 

 

 

 

Financial assets at fair value through profit or loss

6

35,792

33,202

36,652

Trade and other receivables

 

687

572

678

 

 

36,479

33,774

37,330

Current assets

 

 

 

 

Trade and other receivables

 

757

467

368

Cash on fixed term deposit

 

3,016

6,000

1,992

Cash and cash equivalents

 

16,990

14,078

15,444

 

 

20,763

20,545

17,804

Liabilities

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

(188)

(179)

(284)

Net current assets

 

20,575

20,366

17,520

Net assets

 

57,054

54,140

54,850

 

 

 

 

 

Shareholders' equity

 

 

 

 

Share capital

 

9,584

8,881

8,939

Share premium account

 

16,598

13,079

13,337

Capital redemption reserve

 

88

88

88

Other reserve

 

2

2

2

Merger reserve

 

5,525

5,525

5,525

Capital reserve

 

18,997

22,324

20,781

Investment holding gains and losses

 

4,839

3,340

5,127

Revenue reserve

 

1,421

901

1,051

Total shareholders' equity

 

57,054

54,140

54,850

Net asset value per ordinary share

7

61.0p

62.5p

62.9p

 

Unaudited Statement of Changes in Equity

for the six months ended 30 June 2016

Share

capital

Share

premium

account

Other

reserves*

Merger

reserve

Capital

reserve

Investment

holding

gains and

losses

Revenue

reserve

Total

equity

 

£000

£000

£000

£000

£000

£000

£000

£000

At 31 December 2014

6,447

342

90

5,525

24,822

1,507

600

39,333

Revenue profit before taxation

-

-

-

-

-

-

645

645

Capital expenses

-

-

-

-

(295)

-

-

(295)

Investment holding gain on investments held at fair value

-

-

-

-

 

1,709

-

1,709

Realisation of investments

-

-

-

-

(53)

-

-

(53)

Taxation

-

-

-

-

76

-

(76)

-

Total comprehensive (expense) income for the period

-

-

-

-

(272)

1,709

569

2,006

Issue of ordinary share capital

2,366

13,056

-

-

-

-

-

15,422

Issue of shares - DRIS

68

329

-

-

-

-

-

397

Issue costs of ordinary shares

-

(648)

-

-

(94)

-

-

(742)

Purchase of own shares

-

-

-

-

(123)

-

-

(123)

Dividends

-

-

-

-

(1,885)

-

(268)

(2,153)

Total transactions with owners

2,434

12,737

-

-

(2,102)

-

(268)

12,801

Realisation of prior year investment holding losses

-

-

-

-

(124)

124

-

-

At 30 June 2015

8,881

13,079

90

5,525

22,324

3,340

901

54,140

Revenue profit before taxation

-

-

-

-

-

-

640

640

Capital expenses

-

-

-

-

(406)

-

-

(406)

Investment holding gain on investments held at fair value

-

-

-

-

-

1,607

-

1,607

Realisation of investments

-

-

-

-

285

-

-

285

Taxation

-

-

-

-

76

-

(76)

-

Total comprehensive (expense) income for the period

-

-

-

-

(45)

1,607

564

2,126

Issue of shares - DRIS

58

277

-

-

-

-

-

335

Issue costs of ordinary shares

-

(19)

-

-

2

-

-

(17)

Dividends

-

-

-

-

(1,320)

-

(414)

(1,734)

Total transactions with owners

58

258

-

-

(1,318)

-

(414)

(1,416)

Realisation of prior year investment holding losses

-

-

-

-

(180)

180

-

-

At 31 December 2015

8,939

13,337

90

5,525

20,781

5,127

1,051

54,850

Revenue profit before taxation

-

-

-

-

-

-

722

722

Capital expenses

-

-

-

-

(412)

-

-

(412)

Investment holding gain on investments held at fair value

-

-

-

-

-

262

-

262

Realisation of investments

-

-

-

-

186

-

-

186

Taxation

-

-

-

-

75

-

(75)

-

Total comprehensive (expense) income for the period

-

-

-

-

(151)

262

647

758

Issue of ordinary share capital

568

3,030

-

-

-

-

-

3,598

Issue of shares - DRIS

77

366

-

-

-

-

-

443

Issue costs of ordinary shares

-

(135)

-

-

-

-

-

(135)

Purchase of own shares

-

-

-

-

(138)

-

-

(138)

Dividends

-

-

-

-

(2,045)

-

(277)

(2,322)

Total transactions with owners

645

3,261

-

-

(2,183)

-

(277)

1,446

Realisation of prior year investment holding gains

-

-

-

-

550

(550)

-

-

At 30 June 2016

9,584

16,598

90

5,525

18,997

4,839

1,421

57,054

*Other reserves include the capital redemption reserve and the other reserve

Reserves available for distribution

Under the Companies Act 2006 the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

 

Capital

reserve

£000

Revenue

reserve

£000

Total

£000

Distributable reserves as above

18,997

1,421

20,418

Less: Interest and dividends not yet distributable

-

(828)

(828)

: Deferred proceeds

(105)

-

(105)

: Cancelled share premium not yet distributable

(1,343)

-

(1,343)

Reserves available for distribution**

17,549

593

18,142

** The revenue reserve of £593,000 is only distributable once the interim financial statements are filed at Companies House.

The capital reserve (£18,997,000) and the revenue reserve (£1,421,000) are both distributable reserves. These reserves total £20,418,000, representing a decrease of £1,414,000 in the period since 31 December 2015. The directors also take into account the level of investment holding gains (losses) reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £20,418,000 shown above, £828,000 relates to interest and dividends receivable from 2018 onwards, £105,000 of deferred proceeds receivable in 2016, and £1,343,000 of share premium which becomes distributable from 1 January 2018.

On filing the interim financial statements at Companies House, the reserves available for distribution will be £18,142,000.

 

Unaudited Statement of Cash Flows

for the six months ended 30 June 2016

 

Note

Unaudited

6 months

ended

30 June

2016

Unaudited

6 months

ended

30 June

2015

Audited

year

ended

31 December

2015

 

 

£000

£000

£000

Profit before taxation

 

758

2,006

4,132

(Decrease) increase in trade and other payables

 

(96)

(26)

24

Increase in trade and other receivables

 

(122)

(116)

(345)

(Gains) / losses on disposal of investments

 

(186)

53

(232)

Profit on investments held at fair value

 

(262)

(1,709)

(3,316)

Capitalised interest and dividends

 

(20)

(1)

(116)

Net cash inflow from operating activities

 

72

207

147

Cash flows from investing activities

 

 

 

 

Purchase of financial assets at fair value through profit or loss

 

(1,050)

(4,161)

(7,239)

Proceeds from sale of financial assets at fair value through profit or loss

 

2,099

582

2,458

Deferred consideration

 

2

14

13

Cash placed on fixed term deposit

 

(1,024)

(6,000)

(1,992)

Net cash inflow (outflow) from investing activities

 

27

(9,565)

(6,760)

Cash flows from financing activities

 

 

 

 

Issue of ordinary shares

 

3,598

15,126

15,422

Costs of ordinary share issues

 

(135)

(446)

(733)

Purchase of own shares

 

(138)

(123)

(123)

Dividends paid

4

(2,321)

(2,151)

(3,874)

Shares issued under DRIS

 

443

397

732

 

 

 

 

 

Net cash inflow from financing activities

 

1,447

12,803

11,424

 

 

 

 

 

Net increase in cash and cash equivalents

 

1,546

3,445

4,811

Cash and cash equivalents at the beginning of the period

 

15,444

10,633

10,633

Cash and cash equivalents at the end of the period

 

16,990

14,078

15,444

 

Explanatory Notes to the Unaudited Condensed Financial Statements

1 General information, basis of preparation and principal accounting policies

These half year statements have been approved by the directors whose names appear at note 9, each of whom has confirmed that to the best of his knowledge:

• The interim management report includes a fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules.

• The half year statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The half year statements are unaudited and have not been reviewed by the auditors pursuant to the Auditing Practices Board (APB) guidance on Review of Interim Financial Information. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2015 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 December 2015. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the half year statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 December 2015.

The financial statements for the year ended 31 December 2015 were prepared in accordance with the International Financial Reporting Standards (IFRSs) as adopted by the European Union and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. Where guidance set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies in November 2014 ("SORP") is consistent with the requirements of IFRS, the financial statements have been prepared in compliance with the recommendations of the SORP.

Standards and interpretations have been issued which will be effective for future reporting periods but have not been adopted early in these financial statements. These include amendments to IFRS 9, 10 and 15, and amendments to IAS 27 and 28. A full assessment of the impact of the new accounting standards and amendments applicable to the Company has not been carried out, but is not expected to be material to the financial statements.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these half year statements were approved. As at 30 June 2016 the Company held cash balances and fixed term deposits with a combined value of £20,006,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy. The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half year statements.

2 Income

 

Unaudited

6 months

ended

30 June

2016

£000

Unaudited

6 months

ended

30 June

2015

£000

Income from investments

 

 

- Dividends from unquoted companies

340

240

- Dividends from AIM quoted companies

7

24

 

347

264

- Interest on loans to unquoted companies

640

627

Income from investments held at fair value through profit or loss

987

891

Interest on bank deposits

96

74

 

1,083

965

3 Taxation

 

Unaudited 6 months ended

30 June 2016

Unaudited 6 months ended

30 June 2015

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£000

£000

£000

£000

£000

£000

Profit before taxation

722

36

758

645

1,361

2,006

Profit before taxation multiplied by standard small company rate of corporation tax in UK of 20% (2015: 20%)

144

7

151

129

272

401

Effect of:

 

 

 

 

 

 

UK dividends received

(69)

-

(69)

(53)

-

(53)

Non-taxable profits on investments

-

(90)

(90)

-

(331)

(331)

Excess expenses

-

8

8

-

(17)

(17)

Tax charge (credit)

75

(75)

-

76

(76)

-

 

The Company has no provided, or unprovided, deferred tax liability in either period.

Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

4 Dividends

Amounts recognised as distributions to equity holders in the period:

 

Unaudited

6 months ended

30 June 2016

Unaudited

6 months ended

30 June 2015

Audited

Year ended

31 December 2015

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£000

£000

£000

£000

£000

£000

£000

£000

£000

Final dividend for the year ended 31 December 2015 of 2.5p (2014 year end 2.5p) per ordinary share

277

2,045

2,322

268

1,885

2,153

268

1,885

2,153

Interim dividend for the year ended 31 December 2015 of 2.0p per ordinary share

-

-

-

-

-

-

414

1,320

1,734

 

277

2,045

2,322

268

1,885

2,153

682

3,205

3,887

Unclaimed dividends

 

 

(1)

 

 

(2)

 

 

(13)

Dividends paid in the Statement of Cash Flows

 

 

2,321

 

 

2,151

 

 

3,874

 

An interim dividend of 2.0 pence per ordinary share, amounting to approximately £1.87 million is proposed. The dividend has not been recognised in these half year financial statements as the obligation did not exist at the balance sheet date.

5 Basic and Diluted Earnings per Ordinary Share

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to equity shareholders of £758,000 (30 June 2015: £2,006,000) and 92,656,544 (30 June 2015: 79,407,872) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue earnings per ordinary share is based on the revenue profit attributable to equity shareholders of £647,000 (30 June 2015: £569,000) and 92,656,544 (30 June 2015: 79,407,872) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital earnings per ordinary share is based on the capital profit attributable to equity shareholders of £111,000 (30 June 2015: £1,437,000) and 92,656,544 (30 June 2015: 79,407,872) ordinary shares being the weighted average number of ordinary shares in issue during the period.

During the period the Company allotted 763,247 new ordinary shares in respect of its dividend re-investment scheme and 5,683,709 ordinary shares of 10 pence each under the Offer for Subscription launched on 8 December 2015, raising gross proceeds of £3.6 million.

The Company has repurchased 239,530 of its own shares in the period and these shares are held in the capital reserve. The total of 2,367,533 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period. The Company has no securities that would have a dilutive effect and hence basic and diluted earnings per ordinary share are the same.

The only potentially dilutive shares are those shares which, subject to certain criteria, being achieved in the future, may be issued by the Company to meet its obligations under the Investment Advisor Agreement. No such shares have been issued or are currently expected to be issued. There are, therefore, considered to be no potentially dilutive shares in issue at 30 June 2016, 31 December 2015 or 30 June 2015.

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13, in respect of financial instruments that are measured in the balance sheet at fair value, requires disclosure of fair value measurements by level within the following fair value measurement hierarchy:

Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. These instruments are included in Level 1 and comprise AIM quoted investments or government securities and other fixed income securities classified as held at fair value through profit or loss.

Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.

Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as earnings multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2015: none). The change in fair value for the current and previous year is recognised through profit or loss.

All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Initial Measurement: Financial assets are initially measured at fair value. The best estimate of the initial fair value of a financial asset that is either quoted or not quoted in an active market is the transaction price (i.e. cost).

Subsequent Measurement: The International Private Equity and Venture Capital (IPEVC) Valuation Guidelines ("the Guidelines") identify six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market based data in order to derive a fair value.

Full details of the methods used by the Company were set out on pages 55 and 56 of the financial statements for the year ended 31 December 2015, a copy of which can be found at www.bscfunds.com. Where investments are in quoted stocks, fair value is set at the market price.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Price of recent investment, reviewed for change in fair value. This represents the cost of the investment or the price at which a significant amount of new investment has been made by an independent third party adjusted, if necessary, for factors relevant to the background of the specific investment. The value of the investment is assessed for changes or events that would imply either a reduction or increase to its fair value through comparison of financial, technical and marketing milestones set at the time of investment. Where it is considered that the fair value no longer approximates to the cost of the recent investment an estimated adjustment to the cost, based on objective data, will be made to the investment's carrying value.

Earnings multiple. A multiple that is appropriate and reasonable, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of that company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies.

Movements in investments at fair value through profit or loss during the six months to 30 June 2016 are summarised as follows:

IFRS 13 measurement classification

Level 3

Unquoted

Investments

£000

Level 1

Quoted

Equity

Investments

£000

Total

Investments

£000

Opening cost

29,332

2,223

31,555

Opening investment holding gain

4,636

461

5,097

Opening fair value at 1 January 2016

33,968

2,684

36,652

Additions at cost

1,050

-

1,050

Capitalised interest and dividends

20

-

20

Disposal proceeds

(1,363)

(992)

(2,355)

Net profit on disposal *

72

91

163

Change in fair value

214

48

262

Closing fair value at 30 June 2016

33,961

1,831

35,792

Closing cost

29,462

1,521

30,983

Closing investment holding gain **

4,499

310

4,809

Closing fair value at 30 June 2016

33,961

1,831

35,792

* The net profit on disposal in the table above is £163,000 whereas that shown in the Statement of Comprehensive Income is £186,000. The difference comprises the gain of £23,000 arising on deferred proceeds in respect of assets which have been disposed and are not included within the investment portfolio at the period end.

** Following the merger between the Company and British Smaller Technology Companies VCT plc, a total of £975,000 of negative goodwill was recognised in the investment holding gains and losses reserve in respect of investments acquired. The relevant amount per investment is released at the point of disposal to the capital reserve, At 30 June 2016, a total of £30,000 was held on investments yet to be realised in the investment holding gains and losses reserve.

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in fair value of financial assets held at the price of recent investment, or to adjust earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative the value of the unquoted investments would be £2,840,000 (8.4 per cent) lower. Using the upside alternative the value would be increased by £2,907,000 (8.6 per cent).

Of the Company's equity investments 95 per cent are in unquoted companies held at fair value (31 December 2015: 93 per cent). The valuation methodology for these investments includes the application of externally produced FTSE® PE multiples. Therefore the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using an earnings multiple methodology include judgements regarding the level of discount applied to that multiple. A 10 per cent decrease in the discount applied would have increased the net assets attributable to the Company's shareholders and the total profit by £1,531,000 (2.7 per cent of net assets). An equal change in the opposite direction would have decreased net assets attributable to the Company's shareholders and the total profit by £1,443,000 (2.5 per cent of net assets).

Of the Company's equity investments, 5 per cent are quoted on AIM (31 December 2015: 7 per cent). A five per cent increase in stock prices as at 30 June 2016 would have increased the net assets attributable to the Company's shareholders and the total profit for the year by £92,000 (31 December 2015: £134,000). An equal change in the opposite direction would have decreased the net assets attributable to the Company's shareholders and the total profit for the period by an equal amount.

There have been no individual reductions in fair value during the period that exceeded five per cent of the total assets of the Company (31 December 2015: none).

The following disposals took place during the period (all companies are unquoted unless otherwise stated).

 

Net

proceeds

from sale

 

Cost

 

Opening

carrying

value as at

1 January

2016

Gain (loss)

over

opening

carrying

value

Profit

(loss)

on

 original

cost

 

 

£000

£000

£000

£000

£000

Loan repayments

 

 

 

 

 

Bagel Nash Group Limited

27

27

27

-

-

Cambrian Park & Leisure Homes Limited

33

33

33

-

-

Harvey Jones Holdings Limited

469

469

469

-

-

Macro Art Holdings Limited

52

52

52

-

-

Wakefield Acoustics

31

31

31

-

-

 

612

612

612

-

-

Equity disposals

 

 

 

 

 

AB Dynamics plc*

503

130

416

87

373

Brady plc*

320

498

314

6

(178)

Callstream Group Limited

742

329

679

63

413

Ellfin Home Care Limited

1

-

-

1

1

Gamma Communications plc*

169

73

171

(2)

96

Silistix Limited

6

-

-

6

6

 

1,741

1,030

1,580

161

711

Total proceeds from disposals

2,353

1,642

2,192

161

711

Deferred consideration

 

 

 

 

 

Primal Pictures Limited

2

-

-

2

2

Deferred consideration received

2

-

-

2

2

Revaluation of deferred consideration

 

 

 

 

 

Callstream Group Limited

11

-

-

11

11

Sirigen Group Limited

12

-

-

12

12

Total proceeds

2,378

1,642

2,192

186

736

* Designates AIM quoted investments

The total proceeds in the table above is £2,378,000, whereas that shown in the Statement of Cash Flows is £2,099,000. The difference comprises deferred consideration and cash received after 30 June 2016.

7 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £57,054,000 (30 June 2015 and 31 December 2015: £54,140,000 and £54,850,000 respectively) and 93,470,001 (30 June 2015 and 31 December 2015: 86,681,566 and 87,262,575 respectively) ordinary shares in issue at 30 June 2016.

The 2,367,533 (30 June 2015 and 31 December 2015: 2,128,003) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 June 2016. The Company has no securities that would have a dilutive effect and hence basic and diluted net asset value per ordinary share are the same.

The only potentially dilutive shares are those shares which, subject to certain criteria being achieved in the future, may be issued by the Company to meet its obligations under the Investment Advisor Agreement. No such shares have been issued or are currently expected to be issued. There are, therefore, considered to be no potentially dilutive shares in issue at 30 June 2016, 31 December 2015 or 30 June 2015.

8 Total Return

Total return per share is calculated on cumulative dividends paid of 50.5 pence per ordinary share (30 June 2015: 46.0 pence per ordinary share and 31 December 2015: 48.0 pence per ordinary share) plus the net asset value as calculated in note 7.

9 Directors

The directors of the Company are: Richard Last, Robert Martin Pettigrew, and Peter Charles Waller.

10 Other Information

Copies of the interim report can be obtained from the Company's registered office: 5th Floor, Valiant Building, 14 South Parade, Leeds, LS1 5QS or from www.bscfunds.com.

11 Interim Dividend for the six months ended 30 June 2016

Further to the announcement of its interim results for the 6 months to 30 June 2016, the Company confirms that an interim dividend of 2.0 pence per ordinary share ("Interim Dividend") will be paid on 26 September 2016 to those shareholders on the Company's register at the close of business on 26 August 2016. The ex-dividend date for the Interim Dividend will be 25 August 2016.

12 Dividend Re-investment Scheme ("DRIS")

The Company offers a dividend re-investment scheme ("DRIS"). The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Interim Dividend is the close of business on 12 September 2016.

 

For further information, please contact:

David Hall YFM Equity Partners Limited Tel 0113 244 1000

Gillian Martin Nplus1 Singer Advisory LLP Tel 0207 496 3000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR XFLFFQVFBBBX
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.